These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study. Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732 [TBL] [Abstract][Full Text] [Related]
83. Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing. Sun BC; Charlesworth CJ; Lupulescu-Mann N; Young JI; Kim H; Hartung DM; Deyo RA; McConnell KJ Ann Emerg Med; 2018 Mar; 71(3):337-347.e6. PubMed ID: 29248333 [TBL] [Abstract][Full Text] [Related]
84. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. Cepeda MS; Fife D; Kihm MA; Mastrogiovanni G; Yuan Y Clin J Pain; 2014 Dec; 30(12):1051-6. PubMed ID: 24370606 [TBL] [Abstract][Full Text] [Related]
85. Patient outcomes after opioid dose reduction among patients with chronic opioid therapy. Hallvik SE; El Ibrahimi S; Johnston K; Geddes J; Leichtling G; Korthuis PT; Hartung DM Pain; 2022 Jan; 163(1):83-90. PubMed ID: 33863865 [TBL] [Abstract][Full Text] [Related]
86. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913 [TBL] [Abstract][Full Text] [Related]
87. The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study. Szmulewicz A; Bateman BT; Levin R; Huybrechts KF Am J Psychiatry; 2021 Jul; 178(7):643-650. PubMed ID: 33900810 [TBL] [Abstract][Full Text] [Related]
88. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns. Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497 [TBL] [Abstract][Full Text] [Related]
89. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198 [TBL] [Abstract][Full Text] [Related]
90. The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program. Kim H; Hartung DM; Jacob RL; McCarty D; McConnell KJ Psychiatr Serv; 2016 Apr; 67(4):397-404. PubMed ID: 26766755 [TBL] [Abstract][Full Text] [Related]
91. Opioid Use During the Six Months After an Emergency Department Visit for Acute Pain: A Prospective Cohort Study. Friedman BW; Ochoa LA; Naeem F; Perez HR; Starrels JL; Irizarry E; Chertoff A; Bijur PE; Gallagher EJ Ann Emerg Med; 2020 May; 75(5):578-586. PubMed ID: 31685253 [TBL] [Abstract][Full Text] [Related]
93. Possible Opioid Shopping and its Correlates. Walker AM; Weatherby LB; Cepeda MS; Bradford D; Yuan Y Clin J Pain; 2017 Nov; 33(11):976-982. PubMed ID: 28145912 [TBL] [Abstract][Full Text] [Related]
94. Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients. Cicero TJ; Mendoza M; Cattaneo M; Dart RC; Mardekian J; Polson M; Roland CL; Schnoll SH; Webster LR; Park PW Postgrad Med; 2019 Apr; 131(3):225-229. PubMed ID: 30794760 [TBL] [Abstract][Full Text] [Related]
95. Association of Household Opioid Availability With Opioid Overdose. Hendricks MA; El Ibrahimi S; Ritter GA; Flores D; Fischer MA; Weiss RD; Wright DA; Weiner SG JAMA Netw Open; 2023 Mar; 6(3):e233385. PubMed ID: 36930154 [TBL] [Abstract][Full Text] [Related]
96. US Emergency Department Visits for Acute Harms From Prescription Opioid Use, 2016-2017. Lovegrove MC; Dowell D; Geller AI; Goring SK; Rose KO; Weidle NJ; Budnitz DS Am J Public Health; 2019 May; 109(5):784-791. PubMed ID: 30896999 [TBL] [Abstract][Full Text] [Related]
97. Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data. Ferris LM; Saloner B; Krawczyk N; Schneider KE; Jarman MP; Jackson K; Lyons BC; Eisenberg MD; Richards TM; Lemke KW; Weiner JP Am J Prev Med; 2019 Dec; 57(6):e211-e217. PubMed ID: 31753274 [TBL] [Abstract][Full Text] [Related]
98. Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk. Naumann RB; Roberts AW; Marshall SW; Skinner AC Med Care; 2019 Mar; 57(3):213-217. PubMed ID: 30629016 [TBL] [Abstract][Full Text] [Related]
99. Prescription opioid use and non-fatal overdose in a cohort of injection drug users. Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628 [TBL] [Abstract][Full Text] [Related]
100. Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012. Carey CM; Jena AB; Barnett ML Ann Intern Med; 2018 Jun; 168(12):837-845. PubMed ID: 29800019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]